| Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity | Immunity |  | | 2026 | 64 | 61 |
|
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | | | 2024 | 1,025 | 651 |
|
| A neutrophil response linked to tumor control in immunotherapy | Cell | | | 2023 | 98 | 163 |
|
| Dendritic cells direct circadian anti-tumour immune responses | Nature | | | 2023 | 812 | 238 |
|
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers | Science |  | | 2023 | 812 | 2 |
|
| Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity | Journal for immunotherapy of cancer | | | 2023 | 53 | 32 |
|
| Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNg-Secreting Lymphocytes and IL12-Producing Dendritic Cells | Cancer immunology research | | | 2022 | 205 | 78 |
|
| Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy | Science Immunology | | | 2021 | 479 | 1,033 |
|
| Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands | Cancer Reports | | | 2021 | 203 | 249 |
|
| Tumor-infiltrating dendritic cell states are conserved across solid human cancers | Journal of Experimental Medicine | | | 2021 | 305 | 580 |
|
